Details for New Drug Application (NDA): 211157
✉ Email this page to a colleague
NDA 211157 describes ENILLORING, which is a drug marketed by Xiromed and is included in one NDA. It is available from three suppliers. Additional details are available on the ENILLORING profile page.
The generic ingredient in ENILLORING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
The generic ingredient in ENILLORING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 211157
| Tradename: | ENILLORING |
| Applicant: | Xiromed |
| Ingredient: | ethinyl estradiol; etonogestrel |
| Patents: | 0 |
Pharmacology for NDA: 211157
| Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 211157
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ENILLORING | ethinyl estradiol; etonogestrel | RING;VAGINAL | 211157 | ANDA | Northstar Rx LLC | 16714-029 | 16714-029-03 | 3 POUCH in 1 CARTON (16714-029-03) / 21 d in 1 POUCH (16714-029-01) |
| ENILLORING | ethinyl estradiol; etonogestrel | RING;VAGINAL | 211157 | ANDA | AvKARE | 42291-478 | 42291-478-03 | 3 POUCH in 1 CARTON (42291-478-03) / 21 d in 1 POUCH (42291-478-11) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | RING;VAGINAL | Strength | 0.015MG/24HR;0.12MG/24HR | ||||
| Approval Date: | Jun 29, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
